MEZIGDOMIDE for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where MEZIGDOMIDE was used for Plasma cell myeloma.
Most Reported Side Effects for MEZIGDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infection | 11 | 39.3% | 2 | 7 |
| Pneumonia | 11 | 39.3% | 2 | 8 |
| Covid-19 | 10 | 35.7% | 2 | 8 |
| Off label use | 8 | 28.6% | 1 | 6 |
| Plasma cell myeloma refractory | 7 | 25.0% | 1 | 6 |
| Delirium | 6 | 21.4% | 0 | 6 |
| Neutropenia | 6 | 21.4% | 2 | 1 |
| Pyrexia | 6 | 21.4% | 0 | 6 |
Other Indications for MEZIGDOMIDE
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)